glp 1 ra drugs list What to know about the new era of GLP-1 The Boom in New Weight

The Effects of Tirzepatide on Kidney Disease As tirzepatide's role has been widely centered around decreasing the incidence of complications of diabetes mellitus, one must consider its impact on the development of diabetic nephropathy and chronic kidney disease (CKD)

Available from: Cited 12/8/2025

Our findings indicate that patients treated with semaglutide, particularly at higher doses such as Wegovy (2.4 mg), exhibited a higher incidence of psychiatric outcomes compared to non-GLP-1 RA users

Study: Survival and Recurrence With GLP-1 Receptor Agonists in Breast Cancer

The results showed that tirzepatide did not exacerbate their existing heart problems and improved their heart health markers [68, 73, 74]

D.et al